Research Facility

Nashville, Tennessee 37232

1 studies enrolling now · 12 studies all time

What they study most

Advanced Cancer, Anemia, Arrhythmias, Carcinoid, Carcinoid Tumor, Chronic Constipation, Chronic Kidney Disease, Chronic Renal Failure, GEP-NET, Gastroenteropancreatic Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor Disease, Hypoactive Sexual Desire Disorder

Studies at this site

• Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs. — Recruiting now
• Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy — Recruiting now
• A Phase 1, Open-Label, Dose-Escalation Study of NEV801, Administered to Patients With Advanced Cancers — Completed
• Long Term Safety of 125 mg Per Day of Oral Azimilide in Patients With Implantable Cardioverter Defibrillator (ICDs) — Completed
• A Double Blind Study for the Treatment of Acute Ulcerative Colitis — Completed
• Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on Hemodialysis — Completed
• Safety & Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on Dialysis — Completed
• Peginesatide for Anemia in Chronic Hemodialysis Patients — Completed
• Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD — Stopped early
• Endometrial Safety Study of Transdermal Testosterone (300 Mcg/Day) in Naturally Postmenopausal Women — Completed
• Safety and Efficacy of Asacol 4.8 g/Day Versus Asacol 2.4 g/Day (ASCEND I) — Completed
• Phase II, Randomized, Placebo-Controlled Study of ATI-7505 in Patients With Chronic Idiopathic Constipation — Stopped early